Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
ReviveMed Inc. is a pioneering biotech company based in Cambridge, MA, at the forefront of AI-driven drug discovery. Specializing in metabolic diseases, ReviveMed utilizes its proprietary artificial intelligence platform to analyze vast amounts of metabolomic data. This innovative approach allows the company to uncover novel disease mechanisms, identify new drug targets, and develop biomarkers for patient stratification. By integrating machine learning with deep biological insights, ReviveMed aims to accelerate the development of effective therapeutics for conditions such as Non-alcoholic Steatohepatitis (NASH), Inflammatory Bowel Disease (IBD), and other metabolic disorders, ultimately transforming patient care.
The Cambridge headquarters serves as the primary center for ReviveMed's research and development, data science operations, artificial intelligence platform development, and corporate administration.
Located within the Cambridge Innovation Center (CIC), offering a collaborative environment and proximity to leading academic institutions (like MIT), research organizations, and other biotech companies.
ReviveMed cultivates a highly innovative, collaborative, and scientifically driven work culture. Employees are typically engaged in cutting-edge research, working in interdisciplinary teams to solve complex biological problems using AI and machine learning.
The Kendall Square location is highly significant, providing ReviveMed with access to a dense network of talent, potential partners, investors, and world-class research facilities, fostering innovation and growth.
While ReviveMed's physical operations are primarily based in its Cambridge, MA headquarters, the company's scientific collaborations, partnerships with pharmaceutical companies, and the potential impact of its therapeutic research are global in scope. They engage with the international scientific community and aim to address diseases affecting populations worldwide.
One Broadway, 14th Floor
Cambridge
MA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ReviveMed Inc' leadership includes:
ReviveMed Inc has been backed by several prominent investors over the years, including:
As of June 2024, there have been no major publicly announced executive hires or departures at ReviveMed Inc. within the last 12 months. The current leadership team appears stable and has been in place for over a year, guiding the company's strategic initiatives.
Discover the tools ReviveMed Inc uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ReviveMed Inc. likely utilizes standard professional email address formats for its employees, typically incorporating the employee's name and the company domain 'revivemed.io'. Common patterns include first name initial followed by last name, or first name separated from last name by a period.
[first_initial][last]@revivemed.io
Format
jdoe@revivemed.io
Example
75%
Success rate
PR Newswire • May 16, 2023
ReviveMed announced it received a $2 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to further develop its AI platform for identifying novel drug targets and therapies for Inflammatory Bowel Disease (IBD)....more
The Bio Report Podcast / ReviveMed Website • June 21, 2023
Dr. Leila Pirhaji, CEO of ReviveMed, was featured on The Bio Report podcast, where she discussed the company's innovative AI-driven platform for drug discovery and its application in developing new therapeutics for complex diseases....more
Business Wire • April 11, 2023
ReviveMed announced its presentation of key scientific findings at the European Association for the Study of the Liver (EASL) Congress 2023, highlighting advancements made using its AI platform in Non-alcoholic Steatohepatitis (NASH) drug discovery....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ReviveMed Inc, are just a search away.